Cargando…

694. Impact of COVID-19 Pandemic on Clostridioides difficile Infection Rates and Risk Factors in Maryland

BACKGROUND: While many Healthcare Associated Infection (HAI) rates increased during the pandemic, inpatient C. difficile infection (CDI) rates declined. We compared pre-pandemic (2018-2019) to interpandemic (2020-2021) data, using Maryland’s population-based surveillance data collected through the E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marceaux-Galli, Kaytlynn, Perlmutter, Rebecca, Blythe, David, Wilson, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677784/ http://dx.doi.org/10.1093/ofid/ofad500.756

Ejemplares similares

Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health–academic collaborative: an evaluation of a quality improvement intervention
por: Rock, Clare, et al.
Publicado: (2022)

1800. Candida Auris and Neighborhood Socioeconomic Vulnerability in Maryland
por: Smith, Lauren Leigh, et al.
Publicado: (2023)

672. Impact of Multistep Testing Algorithm on Hospital Acquired Clostridioides difficile Infection Rates
por: Betancourth, Adriana C, et al.
Publicado: (2023)

2397. Effects of antimicrobial surgical prophylaxis on rates of Clostridioides difficile infection
por: Hayes, Sarah K, et al.
Publicado: (2019)

684. Characteristics of Patients with Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences
por: Guh, Alice, et al.
Publicado: (2023)

2351. Rate and Consequences of Missed Clostridioides (Clostridium) difficile Infection Diagnosis from Non-disclosure of Clostridioides difficile Multiplex PCR Results. Two-Hospital Experience
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

780. How Much Does Prior Hospitalization Contribute to Readmission with Community-onset Clostridioides difficile Infection?
por: Guh, Alice, et al.
Publicado: (2020)

707. Hospital-Onset Clostridioides difficile Infection Rates During COVID-19 Pandemic in the ICU Patients
por: Gavrielatou, Evdokia, et al.
Publicado: (2021)

2347. Impact of Multidisciplinary Review of Clostridioides difficile Testing
por: Foreman, Jena, et al.
Publicado: (2019)

471. Prevalence and Characteristics of Clostridioides difficile Infection in Bangladesh
por: Sofjan, Amelia K, et al.
Publicado: (2018)

2387. Learning the Influence of Individual Clostridioides difficile Infections
por: Mu, Emily, et al.
Publicado: (2019)

400. Rehospitalization of Patients for Recurrent Clostridioides difficile Infection
por: Drwiega, Emily, et al.
Publicado: (2022)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
por: Friedman, Daniel, et al.
Publicado: (2019)

2235. Fecal Biomarkers for Clostridioides difficile Infection in Cancer Patients
por: Olvera, Adilene, et al.
Publicado: (2019)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

2416. Effect of Sequential Universal Bleach Cleaning and Best Practice Alerts on Clostridioides difficile Infection Rates
por: Gand, Kari, et al.
Publicado: (2019)

1092. Tuning Down Clostridioides difficile PCR Sensitivity Reduces Treatment for C. difficile Infection in Toxin-Negative Patients With No Increase in Adverse Outcomes
por: Hitchcock, Matthew, et al.
Publicado: (2018)

801. Patients with Clostridioides difficile Infection Following Dental Antibiotic Prescription
por: Wilson, Geneva M, et al.
Publicado: (2020)

694. The CAGE Study: Prevalence of Acute Gastroenteritis and Enteric Virus Infection in the Community
por: Schmidt, Mark A, et al.
Publicado: (2018)

2418. Determining the Impact of Visitor Contact Precautions on Hospital-Onset Clostridioides difficile Infection Rates: An Agent-Based Simulation Modeling Approach
por: Alagoz, Oguzhan, et al.
Publicado: (2019)

709. Post-Clostridioides difficile Infection Neuroinflammatory Response in an Animal Model
por: Yang, Suemin E, et al.
Publicado: (2023)

674. Host and Pathogen Risk Factors for Fulminant Clostridioides difficile Infection
por: Chua, Hubert C, et al.
Publicado: (2023)

799. Mini Root Cause Analysis Reveals Opportunities for Reducing Clostridioides difficile Infection Rates
por: Turner, Nicholas A, et al.
Publicado: (2020)

710. Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile
por: Gonzales-Luna, Anne, et al.
Publicado: (2018)

840. Clinical Failure Rates Associated with Hemin-induced Metronidazole Resistance in Clostridioides difficile
por: Gonzales-Luna, Anne J, et al.
Publicado: (2019)

694. Prediction Tool for Infective Endocarditis in Beta-hemolytic Streptococcal Bacteremia
por: Hasegawa, Ryo, et al.
Publicado: (2021)

2371. A Multicenter Cohort Study of the Natural History of Clostridioides difficile Colonization and Infection
por: Curry, Scott R, et al.
Publicado: (2019)

129. Evaluation of Two-Step Clostridioides difficile Testing on Treatment Exposure
por: Bennett, Nicholas, et al.
Publicado: (2023)

PT694. Concomitant psychopharmacological treatments during electroconvulsive therapy
por: Chi, Su-Hyuk, et al.
Publicado: (2016)

783. Clostridioides difficile Infection among Maintenance Hemodialysis Patients
por: Radhakrishnan, Parvathi, et al.
Publicado: (2020)

1985. Impact of Suppressing Ciprofloxacin Susceptibility Results on Antibiotic Utilization and Hospital-acquired Clostridioides difficile Infection
por: White, Bryan P, et al.
Publicado: (2019)

2339. Clostridioides difficile: Impact of Active Screening of Asymptomatic Carriers and Testing Stewardship
por: Beth Graham, Mary, et al.
Publicado: (2019)

837. Prior Hospitalizations Among Cases of Community-Associated Clostridioides difficile Infection—10 US States, 2014–2015
por: Hatfield, Kelly M, et al.
Publicado: (2019)

2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019)

2361. Evaluation of a 2-Step Testing Algorithm for Clostridioides difficile Infection
por: Zuccaro, Patricia, et al.
Publicado: (2019)

2368. Molecular Epidemiology of Clostridioides difficile Infections in Pediatric Oncology and Transplant Patients
por: Barbar, Ruba, et al.
Publicado: (2019)

390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection
por: Morrison, Austin R, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q1pdckr56g6rssf7j4ha2omem0